FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021833920> ?p ?o ?g. }

• W2021833920 endingPage "59" @default.
• W2021833920 startingPage "54" @default.
• W2021833920 abstract "Airway hyperresponsiveness is a key feature of human asthma and chronic bronchitis and response to the indirectly acting agonist adenosine 5′-monophosphate (AMP) is thought to reflect underlying airway inflammation. To examine whether airway responsiveness testing (ART) with AMP may be used to differentiate healthy cats from those with asthma (FA) and chronic bronchitis (CB), 24 cats (9 FA, 6 CB, 9 controls) underwent ART with AMP at concentrations of 0.1, 1, 10, 100 and 500 mg/mL using barometric whole body plethysmography. The defined endpoint of ART, an increase in enhanced pause (Penh) exceeding 300% of the post-saline value (baseline), was reached in 9/15 patients (7 FA, 2 CB), but in none of the controls. Mean Penh (±SD) at baseline (BL) was 0.49 ± 0.16 for cases, and 0.54 ± 0.16 for controls, and was significantly increased after AMP challenge in clinical cases (2.62 ± 2.20), but not in controls (0.63 ± 0.30, P < 0.05). After separating responder (R) and non-responder (NR) cases, a more pronounced difference after challenge was found (R: 3.96 ± 1.84, NR: 0.6 ± 0.21, P < 0.001). The provocative concentration of the agonist that increased Penh to 300% of BL (PC Penh 300) in R cases was 52.98 ± 48.04 mg/mL AMP. Age had no influence on the responder status or PC Penh 300. It was concluded that AMP challenge may offer a new method for the identification of cats with lower inflammatory airway disease, and possibly for monitoring disease progression or response to therapy." @default.
• W2021833920 created "2016-06-24" @default.
• W2021833920 creator A5000331559 @default.
• W2021833920 creator A5007352710 @default.
• W2021833920 creator A5066572473 @default.
• W2021833920 creator A5070926090 @default.
• W2021833920 date "2011-01-01" @default.
• W2021833920 modified "2023-10-17" @default.
• W2021833920 title "Airway hyperresponsiveness to adenosine 5’-monophosphate in feline chronic inflammatory lower airway disease" @default.
• W2021833920 cites W1126234772 @default.
• W2021833920 cites W191520685 @default.
• W2021833920 cites W1963809693 @default.
• W2021833920 cites W1974714196 @default.
• W2021833920 cites W1982217388 @default.
• W2021833920 cites W1985490941 @default.
• W2021833920 cites W1990024726 @default.
• W2021833920 cites W1990209375 @default.
• W2021833920 cites W1991061697 @default.
• W2021833920 cites W2020828877 @default.
• W2021833920 cites W2022458419 @default.
• W2021833920 cites W2024777698 @default.
• W2021833920 cites W2032272410 @default.
• W2021833920 cites W2046127887 @default.
• W2021833920 cites W2050464516 @default.
• W2021833920 cites W2055309491 @default.
• W2021833920 cites W2058005634 @default.
• W2021833920 cites W2058337959 @default.
• W2021833920 cites W2058958111 @default.
• W2021833920 cites W2067198121 @default.
• W2021833920 cites W2139606678 @default.
• W2021833920 cites W2139961805 @default.
• W2021833920 cites W2146297600 @default.
• W2021833920 cites W2148925763 @default.
• W2021833920 cites W2153231621 @default.
• W2021833920 cites W2153421219 @default.
• W2021833920 cites W2156323177 @default.
• W2021833920 cites W2164964161 @default.
• W2021833920 cites W2180591207 @default.
• W2021833920 cites W2270897439 @default.
• W2021833920 cites W4232698735 @default.
• W2021833920 cites W4250280224 @default.
• W2021833920 cites W2131472081 @default.
• W2021833920 doi "https://doi.org/10.1016/j.tvjl.2009.10.007" @default.
• W2021833920 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19910226" @default.
• W2021833920 hasPublicationYear "2011" @default.
• W2021833920 type Work @default.
• W2021833920 sameAs 2021833920 @default.
• W2021833920 citedByCount "18" @default.
• W2021833920 countsByYear W20218339202012 @default.
• W2021833920 countsByYear W20218339202013 @default.
• W2021833920 countsByYear W20218339202014 @default.
• W2021833920 countsByYear W20218339202016 @default.
• W2021833920 countsByYear W20218339202017 @default.
• W2021833920 countsByYear W20218339202020 @default.
• W2021833920 countsByYear W20218339202021 @default.
• W2021833920 countsByYear W20218339202022 @default.
• W2021833920 crossrefType "journal-article" @default.
• W2021833920 hasAuthorship W2021833920A5000331559 @default.
• W2021833920 hasAuthorship W2021833920A5007352710 @default.
• W2021833920 hasAuthorship W2021833920A5066572473 @default.
• W2021833920 hasAuthorship W2021833920A5070926090 @default.
• W2021833920 hasConcept C105922876 @default.
• W2021833920 hasConcept C126322002 @default.
• W2021833920 hasConcept C134018914 @default.
• W2021833920 hasConcept C170493617 @default.
• W2021833920 hasConcept C203014093 @default.
• W2021833920 hasConcept C2776042228 @default.
• W2021833920 hasConcept C2776668983 @default.
• W2021833920 hasConcept C2776991684 @default.
• W2021833920 hasConcept C2777397205 @default.
• W2021833920 hasConcept C2778333281 @default.
• W2021833920 hasConcept C2779876172 @default.
• W2021833920 hasConcept C2779904517 @default.
• W2021833920 hasConcept C2992694001 @default.
• W2021833920 hasConcept C42219234 @default.
• W2021833920 hasConcept C71924100 @default.
• W2021833920 hasConcept C73362275 @default.
• W2021833920 hasConcept C90924648 @default.
• W2021833920 hasConceptScore W2021833920C105922876 @default.
• W2021833920 hasConceptScore W2021833920C126322002 @default.
• W2021833920 hasConceptScore W2021833920C134018914 @default.
• W2021833920 hasConceptScore W2021833920C170493617 @default.
• W2021833920 hasConceptScore W2021833920C203014093 @default.
• W2021833920 hasConceptScore W2021833920C2776042228 @default.
• W2021833920 hasConceptScore W2021833920C2776668983 @default.
• W2021833920 hasConceptScore W2021833920C2776991684 @default.
• W2021833920 hasConceptScore W2021833920C2777397205 @default.
• W2021833920 hasConceptScore W2021833920C2778333281 @default.
• W2021833920 hasConceptScore W2021833920C2779876172 @default.
• W2021833920 hasConceptScore W2021833920C2779904517 @default.
• W2021833920 hasConceptScore W2021833920C2992694001 @default.
• W2021833920 hasConceptScore W2021833920C42219234 @default.
• W2021833920 hasConceptScore W2021833920C71924100 @default.
• W2021833920 hasConceptScore W2021833920C73362275 @default.
• W2021833920 hasConceptScore W2021833920C90924648 @default.
• W2021833920 hasIssue "1" @default.
• W2021833920 hasLocation W20218339201 @default.
• W2021833920 hasLocation W20218339202 @default.

• next